Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | TACR1 | P25103 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1578765 | 1.00 | KMT2A (0.41) | KMT2AALDH1A1CA1CA2CA7 | |
| Diphenylsulfane SCHEMBL4401424 | 0.94 | KMT2A (0.37) | KMT2AALDH1A1CA1CA2CA7 | |
| SCHEMBL1674203 | 0.87 | CA1 (0.44) | KMT2ACA1CA2CA7CA9 | |
| SCHEMBL1479599 | 0.87 | CA1 (0.44) | KMT2ACA1CA2CA7CA9 | |
| SCHEMBL2290678 | 0.87 | CA1 (0.44) | KMT2ACA1CA2CA7CA9 | |
| SCHEMBL23292518 | 0.87 | CA1 (0.44) | KMT2ACA1CA2CA7CA9 | |
| SCHEMBL1561831 | 0.83 | CA1 (0.45) | KMT2ACA1CA2CA7CA9 | |
| SCHEMBL2562479 | 0.83 | CA1 (0.45) | KMT2ACA1CA2CA7CA9 | |
| SCHEMBL3751041 | 0.83 | CA1 (0.45) | KMT2ACA1CA2CA7CA9 | |
| SCHEMBL1263178 | 0.83 | CA1 (0.45) | KMT2ACA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4212541-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES AND THEIR INTERMEDIATES | Genzyme Corporation (US) | 2023-07-19 | — | — | EP | disclosed |
| US-20220242899-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | GENZYME CORPORATION | 2022-08-04 | — | — | US | disclosed |
| US-11279725-B2 | Oligosaccharide-protein conjugates | GENZYME CORPORATION (US) | 2022-03-22 | — | — | US | disclosed |
| US-20200216485-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | GENZYME CORPORATION | 2020-07-09 | — | — | US | disclosed |
| EP-3608330-A2 | SYNTHETIC INTERMEDIATES FOR PREPARING OLIGOSACCHARIDE-PROTEIN CONJUGATES | Genzyme Corporation (US) | 2020-02-12 | — | — | EP | disclosed |
| US-10464962-B2 | Oligosaccharide-protein conjugates | GENZYME CORPORATION (US) | 2019-11-05 | — | — | US | disclosed |
| EP-2889043-B1 | Synthetic intermediates for preparing oligosaccharide-protein conjugates | GENZYME CORP (US) | 2019-04-10 | — | — | EP | disclosed |
| US-20180002365-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | GENZYME CORPORATION | 2018-01-04 | — | — | US | disclosed |
| US-9493498-B2 | Oligosaccharide-protein conjugates | GENZYME CORPORATION (US) | 2016-11-15 | — | — | US | disclosed |
| EP-2889043-A2 | Oligosaccharide-protein conjugates | Genzyme Corporation (US) | 2015-07-01 | — | — | EP | disclosed |
| US-20150175643-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | GENZYME CORPORATION | 2015-06-25 | — | — | US | disclosed |
| EP-2465542-B1 | Oligosaccharide-protein conjugates | GENZYME CORP (US) | 2015-01-21 | — | — | EP | disclosed |
| US-8835614-B2 | Oligosaccharide-protein conjugates | GENZYME CORPORATION (US) | 2014-09-16 | — | — | US | disclosed |
| EP-2465542-A1 | Oligosaccharide-protein conjugates | Genzyme Corporation (US) | 2012-06-20 | — | — | EP | disclosed |
| US-20110300120-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | GENZYME CORPORATION | 2011-12-08 | — | — | US | disclosed |
| WO-2010075010-A2 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | GENZYME CORPORATION (US) | 2010-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220242899-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | MAN2B1, GAA, GBA1 | KMT2A 3781/4885ALDH1A1 2313/4885CA1 3117/4885 |
| US-20200216485-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | MAN2B1, GAA, GBA1 | KMT2A 3781/4885ALDH1A1 2313/4885CA1 3117/4885 |
| US-20110300120-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | MAN2B1, GAA, GBA1 | KMT2A 3781/4885ALDH1A1 2313/4885CA1 3117/4885 |
| US-20150175643-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | MAN2B1, GAA, GBA1 | KMT2A 3781/4885ALDH1A1 2313/4885CA1 3117/4885 |
| US-10464962-B2 | Oligosaccharide-protein conjugates | MAN2B1, GAA, GBA1 | KMT2A 3781/4885ALDH1A1 2313/4885CA1 3117/4885 |
| US-11279725-B2 | Oligosaccharide-protein conjugates | MAN2B1, GAA, GBA1 | KMT2A 3781/4885ALDH1A1 2313/4885CA1 3117/4885 |
| US-20180002365-A1 | OLIGOSACCHARIDE-PROTEIN CONJUGATES | MAN2B1, GAA, GBA1 | KMT2A 3781/4885ALDH1A1 2313/4885CA1 3117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.